WinstonWınston
Back
Stock

IQVIA Holdings

IQV
48
Medical - Diagnostics & Research · Healthcare
Also trades as: 0JDM.L GBP 2.60 (-1.23%)
Price
$258.13
-1.85 (-0.71%)
Market Cap
$42.49B
Winston Score
48
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Oct 8, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Mixed
11/30
Growth
Mixed
9/20
Cash Flow
Exceptional
9/10
Stability
Mixed
3/10
Valuation
Good
6/10
Ownership
Good
8/15
Dividends
Not counted
n/a

46 of 95 counted points = Winston Score 48. Pillars marked n/a do not apply to this company and are left out of the total.

Track this stock — start free trial

Share count falling — buybacks

−11.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 195.0M (2021) → 173.5M (2025)

§Winston Score History

The full picture

IQVIA Holdings helps drug companies run clinical trials and understand healthcare data. It provides technology, analytics, and research services that pharmaceutical and biotech companies use to develop and test new medicines. IQVIA is one of the largest contract research organizations in the world, formed from the 2016 merger of IMS Health and Quintiles.

The company earns revenue through long-term service contracts, data subscriptions, and technology platform fees paid mostly by large pharmaceutical clients. It operates in over 100 countries, with significant revenue coming from North America and Europe, and employs roughly 85,000 people. IQVIA's main competitive advantage is its proprietary database of anonymized patient and prescription data, which is difficult for rivals to replicate. The key risk is that if pharmaceutical companies cut research and development spending during economic downturns, demand for IQVIA's clinical trial and data services tends to fall alongside it.

Politician Trades

21 trades / 12mo

4 Congressional buys and 17 sells on IQV in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-0.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

5.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$2.6B cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

IQVIA Holdings is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
32.9%
Modest — 32.9% gross margin
Profit after running costs
Operating Margin
11.6%
Modest — 11.6% operating margin
Return on the money invested
ROCE
10.4%
Below par — 10.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+8.2%
Steady sales growth (+8.2% YoY)
Profit growth
EPS YoY
+16.5%
Earnings growing fast (+16.5% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
209%
Turns 209% of profit into real cash
Spare cash per sale
FCF Margin
12.7%
Converts sales into free cash efficiently (12.7%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.59
Heavy debt load (2.59)
Covers its interest
Interest Cover
2.99x
Tight — interest eats into profit (3.0x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
31.8x
Pricey — P/E 31.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+15.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (31.8 → 16.2)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial